Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic CancerCraig M. Goodwin, Channing J. Der, Adrienne D. Cox et al.|Cancer Research|2022Cited by 160
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell CarcinomaSehrish Javaid, Adrienne D. Cox, Antje Schaefer et al.|Molecular Cancer Therapeutics|2022Cited by 18
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.Mareen Lüthen, Sehrish Javaid, Jennifer E. Klomp et al.|UNC Libraries|2024Cited by 12
RHOA<sup>L57V</sup>drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signalingAntje Schaefer, Channing J. Der, Richard G. Hodge et al.|Science Signaling|2023Cited by 9
Abstract LB-287: Combination therapies with CDK4/6 inhibitors to treat <i>KRAS-</i>mutant pancreatic cancerCraig M. Goodwin, Channing J. Der, Sehrish Javaid et al.|Cancer Research|2019Cited by 1